Buscar resultados de ensayos clínicos

Patrocinado por

Anemia, Hemolytic - 45 Studies Found

Estado Estudiar
Completed Nombre del estudio: Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel
Condición:
  • Thalassemia Alpha
  • Hemolytic Anemia

Fecha: 2009-09-03
Intervenciones: Other: Medical records summary Summary of Medical files and laboratory results.
Completed Nombre del estudio: Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias
Condición:
  • Idiopathic Thrombocytopenic Purpura
  • Anemia, Hemolytic, Autoimmu
    Fecha: 2008-09-08
    Intervenciones: Drug: Alemtuzumab, Rituximab Alemtuzumab 10 mg each 24 hrs subcutaneous for 3 days. Rituximab 100 mg IV
Completed Nombre del estudio: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
Condición:
  • Cold Agglutinin Disease
  • Autoimmune Hemolytic Anemia

Fecha: 2016-02-16
Intervenciones: Drug: Bendamustine, Rituximab Bendamustine, Rituximab
Completed Nombre del estudio: Immunoglobulin Dosage and Administration Form in CIDP and MMN
Condición:
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Multifocal Motor Neuropathy
  • Fecha: 2014-04-09
    Intervenciones: Drug: Immunoglobulins SCIG dosage is individualized for each patient according to previous IVIG dosage
Completed Nombre del estudio: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
Condición: Chronic Lymphocytic Leukemia
Fecha: 2006-03-29
Intervenciones:
  • Biological: rituximab
  • Drug: cyclophosphami
Active, not recruiting Nombre del estudio: Pyruvate Kinase Deficiency Natural History Study
Condición:
  • Pyruvate Kinase Deficiency
  • Congenital Non-Spherocytic Hemolytic Anemia
    Fecha: 2014-01-28
Completed Nombre del estudio: Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
Condición:
  • Sickle Cell Disease
  • Iron Overload
  • He
    Fecha: 2005-05-10
    Intervenciones:
    • Drug: Deferasirox (ICL670) Def
Completed Nombre del estudio: SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain
Condición:
  • Sickle Cell Disease
  • Anemia
  • Anemia, H
    Fecha: 2016-12-22
    Intervenciones: Other: PROMIS for Pain Management App At hospital discharge, the investigators will collect baseline sur
Completed Nombre del estudio: Treatment of Autoimmune Thrombocytopenia (AITP)
Condición:
  • Autoimmune Disease
  • Autoimmune Hemolytic Anemia